Literature DB >> 27588264

Inhibition of choroidal neovascularization by lentivirus-mediated PEDF gene transfer in rats.

Ya-Jie Yu1, Bin Mo1, Lu Liu2, Yan-Kun Yue2, Chang-Li Yue3, Wu Liu1.   

Abstract

AIM: To evaluate the effects of lentivirus-mediated pigment epithelium-derived factor (PEDF) gene transfer performed in treatment of rats with established choroidal neovascularization (CNV), and investigates the mechanism by which PEDF inhibits CNV in rats.
METHODS: Brown Norway (BN) rats (n=204) were induced by exposure to a laser, and then randomly assigned to 3 groups: no treatment; treatments with intravitreal injection of lentivirus-PEDF-green fluorescent protein (GFP) or lentivirus-control GFP (free fluorescent protein). Following induction and treatment, the CNV tissue was assessed for form, size and vessel leakage by fluorescein fundus angiography (FFA), optical coherence tomography (OCT), histopathology, and examination of choroidal flat mounts. VEGF, Flk-1, and PEDF expression were evaluated by real-time polymerase chain reaction (PCR) and Western blot.
RESULTS: A stable laser-induced rat model of CNV was successfully established, and used to demonstrate lentivirus-mediated PEDG gene transfer by intravitreal injection. Expression of green fluorescence labelled PEDF was observed in the retina up to 28d after injection. An intravitreal injection of lentivirus-PEDF-GFP at 7d led to a significant reduction in the size, thickness and area of CNV showed by FFA, OCT and choroidal flat mounts. PEDF was up-regulated while VEGF and Flk-1 were down-regulated in the lentivirus-PEDF-GFP group. The differences in VEGF and Flk-1 expression in the control and lentivirus-PEDF groups at 7, 14, 21 and 28d after laser induction were all statistically significant.
CONCLUSION: Lentivirus-mediated PEDF gene transfer is effective for use in treatment of laser-induced CNV, and PEDF exerts its therapeutic effects by inhibiting expression of VEGF and Flk-1.

Entities:  

Keywords:  Flk-1; choroidal neovascularization; lentivirus; pigment epithelium-derived factor; vascular endothelial growth factor

Year:  2016        PMID: 27588264      PMCID: PMC4990574          DOI: 10.18240/ijo.2016.08.05

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  23 in total

Review 1.  The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis.

Authors:  Ryo Kawasaki; Miho Yasuda; Su Jeong Song; Shih-Jen Chen; Jost B Jonas; Jie Jin Wang; Paul Mitchell; Tien Y Wong
Journal:  Ophthalmology       Date:  2010-01-27       Impact factor: 12.079

2.  Comparison of the effects between intravitreal and periocular injections of adenoviral vectored pigment epithelium-derived factor on suppressing choroidal neovascularization in rats.

Authors:  Hua Yan; Jing Cui; Ying Wang; Yanping Yu
Journal:  Ophthalmic Res       Date:  2012-12-18       Impact factor: 2.892

3.  Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization.

Authors:  Irina Semkova; Sascha Fauser; Alexandra Lappas; Neil Smyth; Norbert Kociok; Bernd Kirchhof; Mats Paulsson; Vassiliki Poulaki; Antonia M Joussen
Journal:  FASEB J       Date:  2006-06-28       Impact factor: 5.191

4.  Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells.

Authors:  Kyoko Ohno-Matsui; Takeshi Yoshida; Tomoko Uetama; Manabu Mochizuki; Ikuo Morita
Journal:  Biochem Biophys Res Commun       Date:  2003-04-11       Impact factor: 3.575

5.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis.

Authors:  D W Dawson; O V Volpert; P Gillis; S E Crawford; H Xu; W Benedict; N P Bouck
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

6.  AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization.

Authors:  Keisuke Mori; Peter Gehlbach; Satoru Yamamoto; Elia Duh; Donald J Zack; Quihong Li; Kenneth I Berns; Brian J Raisler; William W Hauswirth; Peter A Campochiaro
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-06       Impact factor: 4.799

7.  Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.

Authors:  Christian J Streck; Youbin Zhang; Junfang Zhou; Catherine Ng; Amit C Nathwani; Andrew M Davidoff
Journal:  J Pediatr Surg       Date:  2005-01       Impact factor: 2.545

8.  VEGF is major stimulator in model of choroidal neovascularization.

Authors:  N Kwak; N Okamoto; J M Wood; P A Campochiaro
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-09       Impact factor: 4.799

9.  Inhibition of choroidal neovascularization via brief subretinal exposure to a newly developed lentiviral vector pseudotyped with Sendai viral envelope proteins.

Authors:  Yusuke Murakami; Yasuhiro Ikeda; Yoshikazu Yonemitsu; Masanori Miyazaki; Makoto Inoue; Mamoru Hasegawa; Katsuo Sueishi; Tatsuro Ishibashi
Journal:  Hum Gene Ther       Date:  2010-02       Impact factor: 5.695

10.  Identification of a novel vascular endothelial growth factor receptor 2 inhibitor and its effect for choroidal neovascularization in vivo.

Authors:  Hidenori Takahashi; Yasuhiro Tamaki; Nobuya Ishii; Nobuhiro Oikawa; Eisaku Mizuguchi; Jasmine H Francis; Yuji Inoue; Aya Iriyama; Ryo Obata; Yasuo Yanagi
Journal:  Curr Eye Res       Date:  2008-11       Impact factor: 2.424

View more
  8 in total

Review 1.  LncRNAs in ocular neovascularizations.

Authors:  Yacouba Cissé; Lang Bai; Min-Ting Chen
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

2.  Effect of integrin α5β1 inhibition on SDF-l/CXCR4-mediated choroidal neovascularization.

Authors:  Yang Lyu; Wen-Qin Xu; Li-Juan Sun; Xiao-Yan Pan; Jian Zhang; Yu-Sheng Wang
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

3.  Salvianolic Acid A Inhibits OX-LDL Effects on Exacerbating Choroidal Neovascularization via Downregulating CYLD.

Authors:  Ke Mao; Wanting Shu; Libin Liu; Qing Gu; Qinghua Qiu; XingWei Wu
Journal:  Oxid Med Cell Longev       Date:  2017-09-01       Impact factor: 6.543

Review 4.  Retinal and choroidal angiogenesis: a review of new targets.

Authors:  Thiago Cabral; Luiz Guilherme M Mello; Luiz H Lima; Júlia Polido; Caio V Regatieri; Rubens Belfort; Vinit B Mahajan
Journal:  Int J Retina Vitreous       Date:  2017-08-21

Review 5.  The functions and applications of A7R in anti-angiogenic therapy, imaging and drug delivery systems.

Authors:  Lu Lu; Hongyuan Chen; Dake Hao; Xinke Zhang; Fengshan Wang
Journal:  Asian J Pharm Sci       Date:  2019-05-25       Impact factor: 6.598

6.  Pigment Epithelium-Derived Factor-Loaded PEGylated Nanoparticles as a New Antiangiogenic Therapy for Neovascularization.

Authors:  Feng Zhao; Wenlei Fei; Zhouyue Li; Hanyang Yu; Lei Xi
Journal:  J Diabetes Res       Date:  2022-04-22       Impact factor: 4.061

Review 7.  Delivery Systems of Retinoprotective Proteins in the Retina.

Authors:  Ivan T Rebustini; Alexandra Bernardo-Colón; Alejandra Isasi Nalvarte; S Patricia Becerra
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

8.  Effects of lentivirus-mediated endostatin on endothelial progenitor cells.

Authors:  Jing Ai; Jun-Hui Sun; Jian Ma; Ke Yao
Journal:  Oncotarget       Date:  2017-10-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.